I'm told that as we push deeper into the second half of 2026, institutional investors are quietly reallocating into a basket of niche market leaders spanning semiconductor metrology, satellite imaging, and specialized logistics. This isn't just random sector rotation; it's a calculated bet on companies providing essential underlying infrastructure and supply chain resilience.

Camtek (CAMT.US)

The expansion pace of Camtek (CAMT.US) is hard to ignore. According to people familiar with the matter, the semiconductor inspection equipment maker finalized a USD 100 million acquisition of FormFactor's FRT Metrology business in September 2026, marking its most significant overhaul in advanced packaging inspection. With trailing 12-month revenue hitting USD 509 million by mid-2026, Camtek has been outperforming many peers in the equipment space recently.

MKS Instruments (MKSI.US)

MKS Instruments (MKSI.US)—now rebranded as MKS Inc—is accelerating its global footprint. I've learned that the company broke ground on a new super-center in Penang, Malaysia, in October 2026 to meet surging demand from Asian fab expansions. Its fundamentals remain rock solid, boasting a trailing 12-month revenue of USD 4.35 billion through Q2 2026.

Satellogic (SATL.US)

The satellite imaging platform is experiencing a major financial and managerial turning point in 2026. Satellogic (SATL.US) not only reported its first-ever positive operating income and EBITDA in Q2 but also appointed former NGA director Frank Whitworth as President in September. I'm told the company, chaired by former Treasury Secretary Steven Mnuchin, is actively expanding facilities to chase lucrative sovereign deals, driving notable momentum this year.

United Parcel Service (UPS.US)

Amid ongoing supply chain turbulence, United Parcel Service (UPS.US) remains the ultimate economic bellwether. Internal communications suggest management is cautiously optimistic about cost controls for the 2025-2026 cycle, projecting total revenue to hover around USD 88.7 billion. Even without flashy recent acquisitions, its massive parcel network is an irreplaceable piece of infrastructure.

Kura Oncology (KURA.US)

In the biotech sector, Kura Oncology (KURA.US) just delivered a blowout performance. I'm told that following the FDA approval of Ziftomenib, the company’s Q2 2026 results topped Wall Street estimates, with trailing 12-month revenue reaching USD 77.2 million. Notably, CEO Troy Wilson stepped in to buy USD 1.24 million worth of shares in late August—a signal that catalyzed a recent upward trend.

WISeKey (WKEY.US)

This cybersecurity and IoT player is undergoing its most significant restructuring in years. Preliminary H1 2026 revenue skyrocketed 115% to USD 11.4 million. I'm told WISeKey (WKEY.US) is also advancing plans to redomicile to the British Virgin Islands and recently joined the Hedera Council in September to deepen its decentralized ecosystem play.

Also

• Power Solutions International (PSIX.US): Backed by major shareholder Weichai, the engine manufacturer logged USD 676 million in trailing 12-month revenue, maintaining a steady hold on industrial end markets.
• Knowles (KN.US): The precision micro-acoustics provider has been relatively quiet lately. However, I understand its market share in hearing health and high-performance audio remains highly defensible, with no major strategic pivots signaled yet.
• Infinera (INFN.US): The optical networking specialist is currently in a news vacuum. Industry insiders point out that as bandwidth demands rise, the company's upcoming product cycle updates will be the next key catalyst to watch.

This article does not constitute investment advice.